Then there's cardiovascular disease; some studies say HRT
is protective, others say it raises risks.
As a female GP in my mid-40s, I see many women with menopausal symptoms whose lives are being made miserable, but they're afraid to take HRT
," she says.
Or does the latest study's finding on combined HRT
add weight to previous concerns?
Our research shows that some previous studies are likely to have underestimated the risk of breast cancer with combined estrogen-progestogen HRT
," Anthony Swerdlow, study leader and professor of epidemiology at the ICR, said (http://www.
The initial data from the WHI trial showed a 37 percent reduction in colon cancer and a 34 percent decrease in hip fractures in HRT
users; however, it also revealed a 26 percent increase in invasive breast cancer, a 29 percent increase in heart attacks, and a 41 percent increase in strokes.
Our 'A+' ratings on HRT
continue to benefit from three notches of group support above the stand-alone credit profile (SACP), as we view the insurer as strategically important to the Hannover Re Group.
If a patient is using HRT
, it is recommended that they do so at the lowest effective dose for the shortest amount of time.
Dr Lars Larsson, from Uppsala University Hospital Sweden, who led the study, said that the team found that even though individual muscle fibres did not change in size, the muscles of HRT
users showed greater strength by generating a higher maximum force compared to non-HRT
says the new volumes represent an increase of 0.
Petrobras confirmed the accord and said the companies would be working closely with the government of the state of Amazonas to increase development of the Solimoes basin, where both Petrobras and HRT
have found oil.
Writing in the Journal of Family Planning and Reproductive Health Care, experts said the Million Women Study in the UK - which has reiterated the link several times - does not in fact establish HRT
as a cause of breast cancer.
The risk was significantly increased for women who began estrogen-only HRT
before menopause or less than five years after menopause.
Using longitudinal data from the population-based prescription database of the county of North Jutland, Denmark, and the Danish Cancer Registry, we examined the risk of developing breast cancer in relation to HRT
in a cohort of 78,380 women aged 40-67 years from 1989 to 2002.
The study noted that from 2002 onward, when the use of HRT
declined, there was a noticeable reduction in heart attacks among women 40 to 79 in the U.
However, Bennett Roth, MD, director of UCLA Medical Center's Esophageal Disorders Center, says the new research isn't a good enough reason to forgo HRT
if you aren't at risk of side effects.